• BX Home
  • Business of Biotechnology: News

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

BUSINESS OF BIOTECHNOLOGY

They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.

Business of Biotechnology is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 3,405 news and 4,708 blog items. Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from like-minded professionals.

News

Recent news on this topic.

Change of climate for former BP executivemore

industry, and what it will take to shift it,' she says.'That is not to say that start-up biotech companies do not have...

Lecture on career opportunitiesmore

Institute at San Diego in US explained about various career paths for both B.Tech and M.Tech Biotechnology graduates as...

Europe drug stocks rally; U.S. indexes mixedmore

Drug and biotech stocks were mixed in U.S. trading Monday afternoon, despite a rally by major European drugmakers.

Biotech 2009 Innovation Corridor Poster Winners Announced Nine poster ...more

Extract not available.

SANYO Develops the Industry's Fastest In Situ H2O2 Cell Culture CO2 In...more

of SANYO Electric Co., Ltd.), based in Wood Dale, IL, provides laboratory equipment for pharmaceutical, life science...

Biotech Stocks: Europe drug stocks rally; Cephalon slidesmore

x (DRG 307.52, +4.14, +1.36%) jumped 1.8% to 308.86 and the NYSE Arca Biotechnology Index /quotes/comstock/10t!btk.

Oncolytics Biotech(R) Inc. Closes US$12.75 Million Unit Offeringmore

CALGARY, AB, Nov. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ('Oncolytics' or the 'Company') (TSX:ONC;...

Research and Markets: Key Development Features of the Chinese Pharma O...more

a rough year to all types of industries worldwide. The financial crisis has significantly altered both pharmaceutical...

View from the Top: Chris Viehbacher, Sanofi-Aventismore

re going to see an awful lot more of a collaborative approach, working with academic research institutions and...

WRAPUP 1-Healthcare reform faces challenges in U.S. Senatemore

drugs for the elderly, reimportation of drugs from lower-cost countries and to bring down the cost of brand-name...

Innovation Goes Downtownmore

architecture for a megadevelopment called One North, which integrates new research and development complexes and...

Justice for Rape Victimsmore

Nov. The writer, professor emeritus of clinical pharmacology at Harvard Medical School, has an investment in the...

Ironwood Pharmaceuticals plans IPOmore

Ironwood Pharmaceuticals, a Cambridge biotechnology company developing a treatment for irritable bowel syndrome,...

Boston Scientific to close Doral plant: Even as Miami-Dade officials t...more

the loss of these plants doesn't mean that state and local leaders are wrong in betting on biotechnology as a future...

Healing Chile's Malaisemore

Innovation Council for Competitiveness, a public-private partnership, is trying to increase ties between universities...

Industry family ties are long tradition [San Gabriel Valley Tribune, W...more

industry: lectric engine-generator combination units are assembled in onca ity [he klahoman, klahoma ity] // : ugusta,...

What the papers saymore

first human trial involving stem cells could begin as early as the new year. Scientists from a US biotechnology company...

How Venture Capital Lost Its Waymore

Capital Assn. Meanwhile, two areas crucial to American progress cry out for capital-intensive investment: clean energy...

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two ...more

Conference on Wednesday, December 2, 2009 at 2:00 p.m. EST and at the 2009 Deutsche Bank Biotech Boston Confab on...

Biotech Stocks: Inovio, Merck gain; Novavax fallsmore

DRG 303.38, +1.55, +0.51%) was up 0.6% at 303.54 while the NYSE Arca Biotechnology Index /quotes/comstock/10t!btk.

New drilling package puts a charge into Oklanoma oil industry: Electri...more

lectric engine-generator combination units are assembled in onca ity [he klahoman, klahoma ity] elated rticles ugusta,...

Augusta, MCG lobby with biotech industry [The Augusta Chronicle, Ga.]more

lobby with biotech industry [he ugusta hronicle, a.] * bject v.: lash layer detection and embed - http://blog.deconcept.

Banks held back by loss worriesmore

the raising to launch Resolor, which treats chronic constipation in women. The issue will be the first European...

HealthCor slams Biogen CEO for outsize pay packagemore

with company comment, share price) BOSTON (Reuters) - Biogen Idec Inc shareholder HealthCor Management LP has slammed...

Healthy profitsmore

of that change reflects industry consolidation, but much of it came through internal growth. From drug makers to...

Top Sources: Business of Biotechnology

  • contrarianprofits.com
  • Forbes.com
  • industry.bnet.com
  • thestreet.com
  • news.bbc.co.uk
  • investorideas.com
  • Reuters
  • BusinessWeek
  • biz.yahoo.com
  • MarketWatch

Most Active Users in this Topic

see all contributors...

Featured White Papers

Post a Job

Jobs in this Topic

Senior Business Systems Analyst Genentech | South San Francisco, CA
Posted: Oct 8
Territory Business Manager, Sacramento Baxter International | Deerfield, IL
Posted: Nov 21
Business Analyst / Clinical Specialist Kforce Technology Staffing | Thousand Oaks, CA
Posted: Nov 7
Business Development Manager Quintiles Transnational | Boston, MA
Posted: Nov 9

Report comment contains invalid characters. ()
cancel
Search Cancel